past
year
microbi
detect
method
genet
base
realtim
pcr
peptid
nucleic
acid
fluoresc
hybrid
coexist
tradit
microbiolog
method
typic
base
identif
individu
genet
target
method
success
potenti
caus
infect
must
suspect
recent
multiplex
pcr
multiplex
rtpcr
use
enabl
broadrang
test
base
panel
suspect
pathogen
pcrelectrospray
ioniz
mass
spectrometri
pcresim
emerg
technolog
capabl
identifi
nearli
known
human
pathogen
either
microbi
isol
directli
clinic
specimen
assay
primer
strateg
design
target
one
broad
pathogen
categori
bacteri
mycobacteri
fungal
viral
broadrang
amplif
follow
detect
mix
amplicon
method
identifi
genet
evid
known
unknown
pathogen
uniqu
approach
support
higher
form
inquiri
ask
follow
question
genet
evid
known
unknown
pathogen
patient
sampl
approach
advantag
tradit
assay
commonli
target
presenc
absenc
one
pathogen
known
genet
composit
review
consid
breadth
publish
literatur
explor
possibl
advantag
limit
implement
pcresim
diagnost
laboratori
practic
microbiologist
associ
microbi
detect
microbi
stain
cultur
phenotyp
analysi
throughout
past
two
decad
geneticbas
detect
method
realtim
pcr
peptid
nucleic
acid
fluoresc
hybrid
coexist
tradit
microbiolog
method
typic
base
detect
individu
genet
target
therefor
prior
suspicion
potenti
caus
infect
typic
requir
within
past
decad
multiplex
pcr
multiplex
rtpcr
implement
enabl
partial
broadrang
test
base
detect
panel
like
pathogen
case
true
broadrang
diagnost
test
achiev
use
capillari
sequenc
pyrosequenc
approach
interrog
clinic
sampl
consensu
primer
amplifi
sequenc
conserv
genet
region
region
bacteria
region
fungi
although
previous
describ
method
remain
engrain
diagnost
laboratori
emerg
new
technolog
pcrelectrospray
ioniz
mass
spectrometri
pcresim
offer
new
approach
capabl
identifi
nearli
known
human
pathogen
directli
clinic
specimen
potenti
identifi
genet
evid
undiscov
pathogen
genet
chang
may
occur
alter
sequenc
use
target
exist
molecular
assay
design
broadrang
targetspecif
identif
pathogen
genet
characterist
pcresim
identifi
minut
quantiti
mixtur
nucleic
acid
therefor
novel
microbi
genet
sequenc
uncov
report
accompani
inform
describ
relationship
close
relat
organ
exampl
pathogen
discoveri
one
situat
stand
exemplifi
potenti
impact
pcresim
technolog
april
technolog
detect
first
us
case
novel
influenza
viru
san
diego
ca
instanc
viru
identifi
novel
genet
relat
influenza
tradit
method
detect
identifi
presenc
biothreat
slow
ibi
technolog
origin
develop
biodefens
public
health
safeti
enabl
rapid
detect
identif
pathogen
clinic
environment
sampl
capabl
autom
analysi
pcr
per
day
deem
strateg
platform
situat
rapid
identif
epidemiolog
surveil
mitig
transmiss
concern
origin
call
triangul
identif
genet
evalu
risk
tiger
ecker
et
al
report
first
use
techniqu
technolog
advanc
ibi
biosensor
system
pcresim
prototyp
instrument
figur
origin
conceiv
ibi
bioscienc
carlsbad
ca
system
coupl
equip
desalt
pcr
product
send
timeofflight
tof
analyz
provid
mass
accuraci
suffici
resolut
discern
base
composit
amplicon
produc
multiplex
pcr
abbott
molecular
de
plain
il
acquir
ibi
technolog
advanc
current
version
instrument
call
plexid
figur
abbott
molecular
support
reagent
classifi
diagnost
use
nfdu
assum
instrument
product
distribut
respons
technic
support
instrument
list
avail
nfdu
assay
provid
tabl
plexid
enabl
rapid
identif
approxim
hour
depend
nucleic
acid
type
character
bacteri
viral
fungal
infecti
organ
analysi
human
dna
plexid
rel
new
one
case
publish
literatur
summar
review
describ
research
perform
prototyp
ibi
molecular
sampl
prepar
method
nucleic
acid
must
extract
either
directli
clinic
specimen
cultiv
microbi
isol
wide
varieti
dna
rna
extract
method
manual
autom
success
use
effect
isol
nucleic
acid
bacteria
virus
mycobacteria
fungi
upstream
pcresim
assay
even
simpl
inexpens
method
boil
follow
centrifug
magnet
beadbas
purif
suffici
applic
includ
genotyp
isol
bacteri
coloni
extract
method
avail
varieti
sampl
type
effici
cell
lysi
achiev
either
mechan
mean
zirconium
bead
via
chemic
lysi
involv
use
chaotrop
agent
commerci
reagent
obtain
compani
qiagen
valencia
ca
kingfish
thermo
scientif
waltham
ambion
austin
tx
accept
sampl
type
includ
environment
sampl
eg
air
sampl
dri
filter
unit
surfac
swab
water
sampl
biolog
sampl
eg
bacteri
coloni
bacteri
viral
cultur
clinic
sampl
eg
throat
swab
nasal
swab
nasopharyng
swab
nasal
wash
sputum
skin
swab
food
sampl
eg
meat
dairi
produc
human
forens
sampl
protocol
avail
hair
teeth
bone
blood
although
mani
extract
method
success
use
upstream
abbott
molecular
nfdu
assay
method
perform
equal
sensit
detect
broad
rang
organ
eg
broad
bacteri
reagent
ultraclean
sampl
prepar
reagent
avail
abbott
molecular
recommend
elimin
background
nucleic
acid
contamin
lack
puriti
affect
result
reagent
acquir
sourc
label
dnase
rnase
free
equat
dnafre
reagent
sampl
prepar
nucleic
acid
dispens
well
microtit
plate
downstream
multiplex
amplif
well
contain
one
pair
broadrang
targetspecif
primer
depend
assay
type
pcr
compon
support
amplif
via
multiplex
pcr
multiplex
rtpcr
pcresim
assay
contain
varieti
purpos
design
primer
set
interrog
common
conserv
variabl
sequenc
found
among
variou
class
organ
small
amplicon
bp
variou
size
gener
depend
speci
microb
present
origin
sampl
amplif
produc
genet
product
uniqu
within
group
organ
microbi
domain
microbi
divis
pcresim
proper
amplif
reli
genet
similar
microbi
genom
exampl
bacteria
highli
conserv
sequenc
sever
chromosom
locat
includ
univers
conserv
region
ribosom
rna
noncod
rna
essenti
proteinencod
gene
illustr
figur
conserv
sequenc
intercal
region
sequenc
divers
serv
prime
site
broadrang
primer
amplifi
sequenc
variou
size
composit
thousand
genet
possibl
exist
broadrang
primer
use
conjunct
speci
strain
characteristicspecif
primer
target
identifi
gene
antibiot
resist
key
pathogen
featur
typic
pcresim
assay
use
mastermix
reagent
optim
use
amplif
reaction
use
multipl
primer
multiplex
amplif
gener
occur
condit
low
stringenc
allow
nonspecif
primer
anneal
paramet
support
mismatch
amplif
requir
identifi
unknown
genom
mutat
within
target
region
amplif
typic
requir
twostep
pcr
protocol
enrich
amplif
import
genet
target
amplif
pcr
product
undergo
extens
desalt
process
inject
mass
spectromet
dedic
analysi
neg
charg
molecul
plexid
system
becom
realiti
variou
attribut
desalt
esi
requir
optim
jiang
et
al
optim
highli
effici
autom
method
purifi
desalt
pcr
product
analysi
esim
use
standard
laboratori
robot
protocol
use
pipett
tip
pack
anionexchang
resin
four
primari
step
tip
pretreat
sampl
load
rins
sampl
elut
sampl
time
use
intern
mass
standard
mass
measur
provid
unambigu
base
composit
pcr
product
sub
ppm
measur
error
neg
ionmod
esi
use
analysi
electrospray
ioniz
move
charg
amplicon
mass
spectromet
via
process
optim
detect
neg
charg
oligonucleotid
ion
definit
ms
sensit
analyt
techniqu
measur
mass
charg
mz
ratio
charg
particl
high
accuraci
optim
process
esi
separ
doublestrand
amplicon
intact
singl
strand
puls
flight
tube
mass
spectromet
high
vacuum
strand
separ
base
mz
lower
mz
ion
travel
faster
reach
detector
earlier
ion
higher
mz
composit
distribut
mass
appear
distribut
peak
correspond
differ
charg
state
call
mass
spectrum
result
mass
spectrum
deconvolut
process
spectra
mathemat
simplifi
demonstr
figur
ac
mass
intact
amplicon
calcul
signal
low
molecular
weight
mol
wt
chemic
nois
elimin
signal
digit
process
result
list
highli
accur
mol
wt
mass
forward
revers
strand
amplicon
amplicon
mass
establish
softwar
algorithm
predict
base
composit
depict
figur
calcul
reli
known
mass
four
nucleic
acid
adenin
guanin
cytosin
thymin
present
amplicon
knowledg
dna
strand
complementar
joint
leastsquar
algorithm
correl
potenti
organ
identif
across
multipl
genet
region
sever
genet
region
amplifi
multipl
genet
composit
compar
curat
databas
narrow
genet
possibl
amplicon
one
unambigu
genet
ident
microb
region
amplifi
vari
organ
assaytyp
depend
undoubtedli
key
element
plexid
system
ibi
biosciencescur
databas
genom
inform
associ
base
composit
ident
thousand
organ
despit
enorm
class
divers
organ
databas
contain
care
select
curat
genet
sequenc
allow
interrog
produc
relev
accur
result
databas
popul
base
need
infecti
diseas
surveil
diagnost
test
forens
scienc
biolog
research
databas
regularli
updat
inform
newli
identifi
microorgan
novel
base
count
pass
curat
process
determin
repres
new
microb
strain
design
primer
determin
base
composit
individu
organ
enter
databas
activ
perform
ibi
scientist
use
sequenc
align
extens
primer
score
mani
sequenc
target
organ
primer
valid
laboratori
includ
databas
summari
microbi
identif
occur
genet
sequenc
match
must
occur
technolog
softwar
base
deduct
sever
known
assumpt
potenti
genet
target
known
present
multiplex
primer
set
ii
base
composit
forward
revers
amplicon
strand
must
complementari
therefor
particular
mz
ratio
limit
number
possibl
iii
singl
uniqu
base
composit
possibl
base
composit
must
consist
measur
mass
final
iv
uniqu
base
composit
amplicon
compar
ibi
databas
entri
link
base
composit
primer
pair
small
list
candid
microb
plexid
rapid
bioidentif
system
provid
complet
inform
manag
instrument
control
track
mass
spectral
signal
process
analysi
origin
sampl
organ
identif
extract
amplif
step
plexid
process
fulli
autom
regard
sampl
track
instrument
control
robot
data
process
analysi
comparison
curat
databas
entir
plexid
process
requir
approxim
hour
extract
includ
approxim
hour
amplif
process
event
pcr
amplif
sampl
dispens
limit
factor
schedul
parallel
maxim
throughput
instrument
postpcr
oninstru
throughput
approxim
hour
approxim
plate
analyz
day
depend
assay
patient
sampl
process
per
plate
result
maximum
throughput
rang
sampl
per
day
upper
rang
achiev
four
thermocycl
avail
pcr
step
plexid
test
process
robot
sampl
track
regist
verifi
plate
barcod
ensur
accur
track
physic
transfer
sampl
spray
data
acquisit
phase
system
also
automat
trigger
spectral
process
data
analysi
raw
data
coupl
togeth
instrument
enabl
continu
autom
work
flow
physic
sampl
result
organ
identif
across
unit
state
plexid
system
place
primarili
infecti
diseas
research
surveil
food
biopharmaceut
test
human
identif
studi
although
commerci
version
technolog
known
plexid
proof
principl
establish
earlier
prototyp
public
describ
pcresim
perform
instrument
summar
follow
section
first
report
use
techniqu
select
agent
use
demonstr
potenti
first
isol
coloni
bacillu
anthraci
analyz
illustr
abil
detect
amplicon
deriv
base
composit
compar
result
highresolut
fouriertransform
ion
cyclotron
reson
ms
obtain
tof
mass
analyz
author
conclud
detect
revers
compliment
amplicon
mass
accuraci
requir
deriv
singl
put
base
composit
measur
mol
wt
mass
accuraci
typic
tof
experi
use
postcalibr
approxim
ppm
indic
tofm
suffici
mass
analysi
first
report
occurr
plagu
afghanistan
use
pcresim
select
agent
identif
yersinia
pesti
identifi
postmortem
analysi
outbreak
acut
gastroenter
associ
consumpt
handl
camel
meat
molecular
test
patient
sampl
tissu
camel
use
pcresim
reveal
dna
signatur
consist
pesti
confirmatori
test
use
realtim
pcr
immunolog
seroconvers
one
patient
confirm
outbreak
caus
pesti
bacteri
identif
genotyp
use
detect
infect
biosurveil
activ
clinic
public
health
sector
classic
genotyp
perform
varieti
method
includ
pulsedfield
gel
electrophoresi
pfge
repetit
element
sequencebas
amplif
reppcr
multilocu
sequenc
type
mlst
dna
sequenc
genom
region
contain
genet
variat
genotyp
method
tediou
expens
contrast
pcresim
perform
analysi
rel
eas
strain
genotyp
mode
pcresim
primer
target
gene
contain
highli
variabl
region
use
distinguish
close
relat
strain
within
given
speci
deriv
genotyp
signific
practic
valu
fraction
turnaround
time
tradit
method
therefor
could
enabl
rapid
track
transmiss
infecti
diseas
outbreak
appropri
outbreak
intervent
infect
prevent
measur
culturebas
test
bias
toward
one
organ
thu
bias
true
represent
true
caus
infect
howev
abil
pcresim
identifi
multipl
strain
multipl
organ
may
valuabl
certain
clinic
public
health
set
initi
singl
bacteri
isol
identif
blind
panel
divers
bacteri
speci
human
andor
anim
pathogen
test
accuraci
refin
ibi
databas
sinc
improv
accuraci
report
specif
bacteria
rest
review
depict
potenti
plexid
system
varieti
applic
clinic
specimen
test
directli
identif
multipl
microb
feasibl
point
first
report
describ
test
mix
microb
directli
patient
sampl
depict
militarybas
outbreak
investig
analysi
respiratori
sampl
reveal
high
concentr
pathogen
respiratori
speci
includ
haemophilu
influenza
neisseria
meningitidi
streptococcu
pyogen
pyogen
identifi
sampl
epidem
site
ident
genotyp
found
almost
recruit
kaleta
et
al
perform
pcresim
test
directli
blood
cultur
bottl
compar
result
convent
method
identifi
genu
speci
microorgan
found
caus
human
bloodstream
infect
n
studi
demonstr
high
analyt
accuraci
concord
genu
speci
level
respect
mixtur
microb
identifi
blood
cultur
bottl
includ
mix
speci
genu
mixtur
contain
gramposit
gramneg
organ
exemplifi
abil
identifi
multipl
organ
simultan
without
need
subcultiv
studi
also
report
microb
combin
accur
detect
therefor
method
improv
still
requir
second
studi
compar
matrixassist
laser
desorptionionizationtofm
subcultur
microbi
isol
statist
signific
differ
accuraci
observ
stoodley
et
al
perform
test
evalu
pcresim
use
bacteri
biofilm
observ
mani
prosthesisrel
infect
ankl
arthroplasti
cultur
neg
preoper
aspir
produc
posit
result
via
pcresim
detect
staphylococcu
aureu
staphylococcu
epidermidi
methicillinresist
gene
meca
soft
tissu
associ
explant
hardwar
viabl
multispeci
biofilm
confirm
micrograph
molecular
examin
confoc
microscopi
use
livedead
stain
bacteri
fluoresc
situ
hybrid
rtpcr
bacteri
mrna
result
suggest
pcresim
may
use
adjunct
routin
cultur
detect
biofilm
bacteria
prosthet
joint
infect
use
panel
divers
bacteri
isol
collect
center
diseas
control
prevent
previous
character
mlst
pfge
clinic
isol
two
geograph
distinct
hospit
pcresim
accur
determin
aureu
identif
genotyp
use
primer
design
amplifi
gene
analyz
mlst
method
pcresim
accur
identifi
major
clonal
complex
accuraci
us
pulsedfield
type
accuraci
cluster
result
agreement
reppcr
pfge
make
method
suitabl
use
outbreak
investig
furthermor
wolk
et
al
report
accuraci
highresolut
genet
signatur
identifi
genotyp
determin
encod
antimicrobi
resist
virul
consist
phenotyp
trait
wellcharacter
refer
clinic
isol
aureu
studi
identif
common
toxin
gene
correl
independ
pcr
analys
toxin
gene
molecular
identif
antibioticresist
gene
correl
phenotyp
vitro
resist
sensit
rang
specif
rang
except
erythromycin
sensit
specif
staphylococc
isol
correctli
classifi
genotyp
group
correl
genet
clonal
complex
reppcr
pattern
pfge
type
acinetobact
speci
hujer
et
al
report
accur
resistancedetermin
identif
acinetobact
speci
could
inform
therapeut
decis
make
treatment
infect
use
collect
wellcharacter
multidrugresist
acinetobact
speci
pcresim
accur
identifi
quinolon
resist
mediat
mutat
quinolon
resistancedetermin
region
gyra
parc
highli
conserv
essenti
housekeep
gene
singl
point
mutat
identifi
parc
isol
gyra
isol
overal
result
correl
suscept
test
dna
sequenc
use
isol
collect
infect
colon
soldier
civilian
involv
outbreak
militari
health
care
system
six
housekeep
gene
trpe
adk
efp
muti
fumc
ppa
sequenc
result
compar
analysi
pcresim
use
nine
primer
pair
target
informationrich
region
gene
acinetobact
baumannii
predomin
sampl
set
isol
howev
least
acinetobact
speci
accur
identifi
result
genotyp
agreement
obtain
pfge
analysi
distinguish
baumannii
genotyp
previous
identifi
sequenc
ultim
isol
genotyp
ident
similar
associ
wellcharacter
baumannii
isol
european
hospit
twentyseven
isol
genotyp
repres
differ
acinetobact
speci
includ
eight
repres
acinetobact
genomospeci
repres
genomospeci
schuetz
et
al
investig
related
multidrugresist
baumannii
isol
burn
intens
care
unit
outbreak
nonoutbreak
strain
genotyp
compar
three
molecular
type
method
reppcr
pcresim
pfge
result
pcresim
pfge
genotyp
close
correl
wherea
reppcr
pcresim
system
rapid
molecular
type
analysi
show
outbreak
isol
indistinguish
close
relat
outbreak
strain
repres
novel
strain
type
new
combin
allel
previous
seen
unit
state
challeng
panel
compris
strain
type
campylobact
jejuni
strain
type
campylobact
coli
pcresim
accur
genotyp
c
jejuni
strain
type
resolv
power
compar
mlst
readili
distinguish
c
jejuni
c
coli
pure
bacteri
isol
accuraci
achiev
littl
genom
per
pcr
ehrlicia
speci
identif
achiev
directli
blood
specimen
result
compar
colorimetr
microtit
pcr
enzym
immunoassay
wholeblood
sampl
collect
patient
clinic
suggest
ehrlichiosi
sampl
posit
ehrlichia
speci
pcresim
sensit
specif
posit
neg
predict
valu
respect
specimen
test
posit
pcresim
pcrenzym
immunoassay
specieslevel
agreement
addit
rickettsia
rickettsii
detect
pcresim
four
specimen
confirm
retrospect
serolog
find
pcrenzym
immunoassay
anoth
three
specimen
contain
clinic
relev
bacteri
pathogen
specif
pseudomona
aeruginosa
neisseria
meningitidi
aureu
confirm
cultur
andor
clinic
diagnosi
one
case
studi
bartonella
quintana
identifi
rare
caus
abdomin
aortic
mycot
aneurysm
man
experienc
chronic
back
pain
otherwis
exhibit
sign
infect
simultan
determin
isoniazid
rifampin
resist
mycobacterium
tuberculosi
complex
determin
speci
nontubercul
mycobacteria
massir
et
al
describ
pcresim
use
collect
dna
sampl
cultur
specimen
collect
new
york
russia
south
africa
compar
phenotyp
data
pcresim
achiev
sensit
specif
determin
isoniazid
resist
sensit
specif
determin
rifampin
resist
base
set
previous
character
liquid
cultur
specimen
pcresim
method
sensit
specif
determin
nontubercul
mycobacteria
ident
final
highand
lowpreval
region
china
pcresim
determin
genotyp
drugresist
profil
tuberculosi
isol
date
public
describ
use
pcresim
identif
fungi
gu
et
al
evalu
wellcharacter
strain
clinic
relev
candida
speci
plexid
instrument
set
isol
test
two
method
reppcr
pcr
esim
compar
refer
standard
gene
sequenc
intern
transcrib
spacer
ribosom
rna
gene
reppcr
pcresim
correctli
identifi
isol
speci
level
studi
describ
identif
bloodstream
pathogen
kaleta
et
al
includ
candida
speci
n
recov
blood
cultur
document
agreement
pcresim
versu
vitek
identif
promis
field
influenza
surveil
pandem
prepared
aid
vaccin
strain
select
rapid
rtpcresim
broadrang
influenza
identif
tool
use
simultan
identifi
type
influenza
virus
clinic
specimen
virus
identifi
cladelevel
resolut
viral
popul
use
monitor
global
spread
emerg
novel
viral
genotyp
base
composit
rtpcr
amplicon
influenza
core
gene
segment
pa
ns
np
analyz
provid
subspeci
identif
infer
influenza
viru
h
n
subtyp
one
report
assay
correctli
identifi
mammalian
avian
influenza
isol
repres
differ
h
n
type
includ
avian
isol
furthermor
direct
analysi
human
clinic
respiratori
specimen
collect
period
show
correct
identif
viral
speci
subtyp
sensit
specif
base
compositionderiv
cluster
infer
analysi
show
concord
previous
establish
clade
ongo
surveil
sampl
recent
influenza
viru
season
show
evid
emerg
establish
new
genotyp
circul
strain
worldwid
mix
viral
quasispeci
found
approxim
recent
sampl
provid
view
viral
evolut
subsequ
work
assay
differenti
novel
season
nonhuman
host
virus
demonstr
use
robust
influenza
viru
surveil
detect
novel
unusu
virus
previous
unseen
genom
print
studi
sampl
collect
test
includ
season
swine
tripl
reassort
virus
sampl
clinic
specimen
eg
throat
nasal
nasopharyng
swab
nasal
wash
blood
sputum
use
base
count
signatur
one
first
case
pandem
pcresim
confirm
unusu
previous
unrecogn
influenza
viru
core
gene
relat
virus
avian
human
swine
origin
subsequ
analysi
addit
pandem
sampl
reveal
share
genom
print
differ
north
american
swine
tripl
reassort
virus
season
virus
test
moreov
assay
allow
distinct
core
gene
cocircul
group
season
clade
reassort
dual
antivir
resist
adamantan
oseltamivir
broader
assess
emerg
coronavirus
isol
nine
divers
coronaviru
speci
includ
sever
acut
respiratori
syndromeassoci
coronaviru
test
pcresim
method
identifi
distinguish
sever
acut
respiratori
syndrom
known
coronavirus
includ
human
coronaviru
individu
mixtur
three
human
virus
sensit
detect
estim
approxim
plaqueform
unit
pfu
ml
final
nfdu
respiratori
viral
panel
identifi
respiratori
syncyti
viru
influenza
b
parainfluenza
adenoviru
f
coronaviru
human
metapneumoviru
chen
et
al
test
nasopharyng
aspir
detect
acut
infect
upper
respiratori
tract
found
sensit
identifi
addit
posit
virus
rel
viral
cultur
antigen
detect
rapid
detect
identif
serotyp
human
adenovirus
f
perform
assay
character
use
quantifi
viral
standard
environment
human
clinic
sampl
collect
militari
train
facil
evalu
select
viral
agent
flavivirus
alphavirus
base
rtpcresim
first
studi
involv
evalu
assay
design
detect
tickand
mosquitoborn
flavivirus
panel
differ
flavivirus
analyz
sampl
correctli
identifi
speci
level
limit
detect
mosquitoborn
primer
set
determin
use
rna
west
nile
viru
equival
viral
titer
pfuml
assay
accur
identifi
viru
within
infect
mosquito
includ
aed
aegypti
mosquito
laboratori
infect
viru
use
human
blood
serum
urin
spike
west
nile
viru
mous
blood
brain
tissu
karshi
virusinfect
mice
author
demonstr
clinic
matric
inhibit
detect
virus
final
test
fieldcollect
ixod
scapulari
tick
reveal
infect
rate
tick
posit
deer
tick
viru
subtyp
powassan
viru
assay
detect
multipl
tickand
mosquitoborn
flavivirus
suitabl
epidemiolog
surveil
likewis
member
genu
alphaviru
unambigu
character
speci
subtyp
isol
test
assay
detect
venezuelan
equin
enceph
viru
eastern
equin
enceph
viru
mixtur
pool
consist
laboratoryinfect
laboratoryuninfect
mosquito
furthermor
assay
use
detect
alphavirus
natur
occur
mosquito
vector
distinct
signatur
subsequ
sequenc
analysi
confirm
viru
member
mucambo
viru
speci
subtyp
iiid
venezuelan
equin
enceph
viru
complex
although
pcresim
display
potenti
rapid
multiplex
identif
infecti
agent
sever
key
area
concern
relat
technolog
first
potenti
contamin
instrument
open
platform
potenti
instrument
workspac
expos
amplicon
subsequ
contamin
futur
sampl
process
mitig
concern
imper
maintain
separ
positivepressur
space
reagent
prepar
pcr
strict
unidirect
work
flow
furthermor
januari
exhaust
adaptor
avail
direct
tof
emiss
work
area
second
pcresim
method
capabl
identifi
multipl
organ
singl
sampl
use
broadrang
pcr
howev
limit
identif
mix
infect
pcresim
semiquantit
rel
intens
multipl
organ
determin
allow
select
treatment
manag
multipl
organ
confid
score
also
assign
organ
depend
number
primer
make
identif
good
fit
databas
composit
interpret
mixtur
reli
examin
combin
factor
includ
qualiti
result
q
score
signal
intens
match
expect
base
count
number
primer
produc
result
improv
assess
signal
deriv
mix
infect
requir
prior
clinic
implement
futur
clinic
softwar
version
interpret
score
automat
nfdu
softwar
allow
user
see
contribut
factor
perform
analysi
moreov
sensit
mass
spectrometr
detect
method
potenti
pcr
contamin
environment
organ
concern
publish
studi
address
limit
detect
term
colonyform
unitml
pfuml
report
low
gener
limit
detect
pcr
esim
similar
multiplex
pcr
assay
lowlevel
environment
contamin
may
mitig
use
dnafre
ultrapur
reagent
addit
inspect
semiquantit
measur
rel
number
genom
per
well
import
environment
contamin
would
expect
produc
result
associ
low
genom
per
well
despit
assess
may
difficult
distinguish
environment
contamin
lowlevel
pathogen
appropri
cutoff
valu
posit
signal
need
refin
address
limit
final
addit
concern
pcresim
expect
cost
feasibl
nonrefer
facil
acquir
technolog
expect
startup
cost
plexid
higher
readili
support
diagnost
laboratori
addit
cost
includ
attain
assay
kit
approxim
per
sampl
similar
greater
cost
exist
molecular
assay
combin
expens
startup
kit
make
pcresim
implement
gener
laboratori
difficult
implement
may
within
reach
larger
clinic
refer
laboratori
evalu
potenti
cost
avoid
may
occur
rapid
identif
wide
varieti
infect
may
offset
cost
pcresim
howev
implement
practic
remain
describ
clinic
literatur
futur
technolog
pcresim
could
shift
way
microbiologist
think
diagnosi
infect
appear
accur
flexibl
potenti
implement
larg
refer
laboratori
public
health
surveil
adapt
pcresim
potenti
fundament
chang
way
diagnost
laboratori
perform
microbi
detect
identif
common
microbiolog
premis
rapid
detect
identif
microbi
agent
improv
clinic
financi
outcom
patient
suspect
infect
arguabl
next
frontier
evidencebas
laboratori
intervent
support
clinic
util
rapid
test
mount
past
decad
pcresim
merit
investig
lend
situat
convent
method
prove
noninform
futur
hold
distinct
possibl
pcresi
msbase
diseas
diagnost
certain
set
distinguish
among
method
broadbas
direct
sampl
detect
capabl
abil
detect
target
gene
sequenc
despit
silent
mutat
genet
rearrang
abil
simultan
identifi
speci
genotyp
antimicrobialresist
gene
virul
factor
combin
detect
capabl
never
achiev
one
test
platform
